Bydd y cyllid ar gyfer y buddsoddiadau hyn yn dod drwy daliadau i Gymru gan setliad Cynllun Rheoleiddio Prisiau Fferyllol (PPRS) 2014. Byddant yn helpu GIG Cymru i fonitro'n fwy effeithlon ei wariant o fwy na £198m ar feddyginiaethau yn y sector ysbytai, a chaiff mwyafrif helaeth yr arian hwn ei wario ar feddyginiaethau newydd ac arloesol.
These investments will be met by using payments to Wales from the 2014 Pharmaceutical Price Regulation Scheme (PPRS) settlement. They will help NHS Wales more efficiently martial its expenditure of more than £198m on medicines in the hospital sector, the vast majority of which is spent on new and innovative medicines.